BackSeaport Therapeutics Common Stock Overview

Seaport Therapeutics Common Stock Receivables

Seaport Therapeutics Common Stock's receivables is $4.9M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$4.86M

Peer trimmed avg / median

Loading

Seaport Therapeutics Common Stock Receivables History

Loading

Seaport Therapeutics Common Stock vs. peers: Receivables Comparison

Loading

Seaport Therapeutics Common Stock Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Seaport Therapeutics Common Stock (SPTX) FAQ

Seaport Therapeutics Common Stock (SPTX) currently reports a receivables of $4.9M as of June 2026. Use the charts on this page to explore Seaport Therapeutics Common Stock's receivables history and peer comparisons.

Seaport Therapeutics Common Stock reported $4.9M in receivables as of June 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $4.9M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Seaport Therapeutics Common Stock, and consider following SPTX for alerts when major investors trade the stock.

Seaport Therapeutics Common Stock is classified in the Healthcare sector. On receivables, it currently shows $4.9M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SPTX with unrelated industries.